ClinicalTrials.Veeva

Menu

Adjunctive Effect of Acupuncture for Advanced Cancer Patients With Palliative Care: a Three-arm Randomized Trial

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status

Unknown

Conditions

Advanced Cancer

Treatments

Other: Standard care (SC)
Other: Acupuncture and standard care (ASC)
Other: Sham acupuncture and standard care (SSC)

Study type

Interventional

Funder types

Other

Identifiers

NCT04398875
UW 19-822

Details and patient eligibility

About

The proposed study aims to evaluate the adjunctive effect of MA with standard care (ASC) for relieving cancer-related symptoms in a collaborative model of palliative care compared to sham MA plus standard care (SSC) or standard care alone (SC).

Full description

After being informed about the study plan, potential risk and benefits, all subjects will give written informed consent prior to participation and undergo eligibility screening. Eligible participants will be randomized into three arms, ASC, SSC, and SC, in a 2:1:1 ratio.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All cases are subject to pathology and (or) cytology for a diagnosis of malignant tumour (pathological type is not restricted) at stage IIIB or IV;
  • Aged 18 years or above;
  • Expected survival time longer than 16 weeks;

Exclusion criteria

  • Disseminated intravascular coagulation or severe thrombocytopenia with a bleeding tendency, i.e., low platelet count < 35000/µL; INR > 1.5; hemoglobin ≤ 90 g/dL; white blood cell count ≤ 4x109/L;
  • Uncontrolled active skin infection;
  • Needle phobia;
  • Inability to read and understand Chinese;
  • Not signed written informed consent.
  • Receiving surgery during the whole study period;
  • Receiving acupuncture treatment in the last 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 3 patient groups, including a placebo group

ASC
Experimental group
Description:
Traditional manual acupuncture with standard care (ASC) will be provided. Subjects in the ASC group will receive 9 sessions of acupuncture and standard care for 3 weeks. A semi-standardized acupuncture treatment protocol (combined fixed acupoints with additional acupoints by symptom differentiation) will be employed. The fixed acupuncture points including, Guanyuan (CV4), Xuanzhong(GB39), Sanyinjiao (SP6), Yinlingquan (SP9), Zusanli (ST36), Yingtang (EX-HN3), Baihui (GV20), and Qihai (CV6) will be used in every session.
Treatment:
Other: Acupuncture and standard care (ASC)
SSC
Sham Comparator group
Description:
Sham acupuncture plus standard care (SSC) will be provided. Subjects in the SSC group will receive 9 sessions of sham acupuncture and standard care for 3 weeks. The Streitberger sham acupuncture will be employed. The selection of acupoints is the same as ASC.
Treatment:
Other: Sham acupuncture and standard care (SSC)
SC
Placebo Comparator group
Description:
Standard care alone (SC) will be provided. Subjects in the SC group will standard care for 3 weeks.
Treatment:
Other: Standard care (SC)

Trial contacts and locations

0

Loading...

Central trial contact

Haiyong CHEN, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems